Skip to main content
Alok Khorana, MD, Oncology, Cleveland, OH

AlokA.KhoranaMD

Oncology Cleveland, OH

Gastrointestinal Cancer, Hematologic Oncology

Professor of Medicine, Cleveland Clinic Lerner College of Medicine; Sondra and Stephen Hardis Endowed Chair in Oncology Research; Director GI Malignancies Program; Vice-Chair (Faculty Development), Taussig Cancer Inst, Cleveland Clinic

Dr. Khorana is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Khorana's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    Cleveland, OH 44195
    Phone+1 216-444-6833
    Fax+1 216-444-9423

Summary

  • Alok A. Khorana, M.D., F.A.C.P, F.A.S.C.O, is Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center) and Director of the Gastrointestinal Malignancies Program at the Cleveland Clinic, Cleveland, Ohio. His clinical and translational research program focuses on predictive factors and drug development in cancer-associated thrombosis and gastrointestinal cancers and has been funded by grants from the National Cancer Institute, the National Heart, Lung, and Blood Institute, the Hardis Family, the Porter Family Fund, VeloSano, the Cleveland Clinic Center for Excellence, the Scott Hamilton CARES Initiative, Stand Up To Cancer (Colorectal Cancer “Dream Team”) and the V Foundation.

    Dr. Khorana received his medical degree from Maharaja Sayajirao University’s Medical College in Baroda (now Vadodara, Gujarat), India. His postdoctoral training included a residency in internal medicine at the University at Buffalo in New York and a fellowship in hematology/oncology at the University of Rochester, New York. He is a Fellow of the American College of Physicians and in 2018 was elected Fellow of the American Society of Clinical Oncology.

    Dr. Khorana is Past Chair of the American Society of Clinical Oncology (ASCO) Clinical Practice Guidelines Panel (CPGC), Chair of ASCO CPGC’s Pancreas Cancer Working Group, Co-Chair of ASCO CPGC’s Multisite Advisory Group and Co-Chair of the ASCO Guidelines Panel on Resectable Pancreas Cancer. He is currently Chair of the Medical and Scientific Advisory Board of the National Blood Clot Association. He has also served or serves on the ASCO Scientific Program Committee and multiple Guidelines/Guidance Panels.

Education & Training

  • University of Rochester
    University of RochesterFellowship, Hematology and Medical Oncology, 1999 - 2002
  • University at Buffalo
    University at BuffaloResidency, Internal Medicine, 1996 - 1999
  • Baroda Medical College
    Baroda Medical CollegeClass of 1995

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2013 - 2026
  • NY State Medical License
    NY State Medical License 2002 - 2014
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Maria and Sam Miller Professional Excellence Award for Scientific Achievement in Clinical Research Cleveland Clinic, 2019
  • Teacher of the Year (Medical Oncology) Cleveland Clinic, 2018
  • Meliora Award (Team Award( University of Rochester, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Do Patients with Pancreatic Body or Tail Cancer Benefit from Adjuvant Therapy?A Cohort Study  
    Alok Khorana, MD, ScienceDirect
  • An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index  
    Bewtra Meenakshi, Brensinger Colleen M, Tomov Vesselin T, Hoang Tram B, Sokach Carly E, Siegel Corey A, Lewis James D, Inflammatory Bowel Diseases, 6/1/2014
  • Diagnosis of Dry Eye Disease and Emerging Technologies  
    Zeev MS, Miller DD, Latkany R, Clin Opthalmol, 3/1/2014
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Molecular Subtyping to Predict Risk of Venous Thromboembolism in Patients with Advanced Lung Adenocarcinoma: A Cohort Study
    Alok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Meta-Analysis and Cost-Effectiveness Analysis of Low-Dose Direct Oral Anticoagulant for the Prevention of Cancer Associated Thrombosis
    Alok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical Outcomes of Cancer-Associated Thrombosis Beyond 6 Months of Anticoagulation
    Alok A Khorana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • What's New in VTE? Evaluating the Latest Evidence and Grades of Recommendation 
    60th American Society of Hematology Annual Meeting - 11/30/2018
  • Generosity: Normal and Pathological 
    Weill Cornell Medical School, New York, NY - 10/15/2014
  • Join now to see all

Other

  • Vaginal Hysterectomy. Videotape 
    Ling FW, Shull B, Hurt G, Stovall TG, Porges R, Lipscomb GH, Copyright: Council on Resident Education in Obstetrics and Gynecology
    1/1/1995

Press Mentions

  • Cleveland Clinic Research Reveals Unique Tumor-Related Bacteria Tied to Young-Onset Colorectal Cancer
    Cleveland Clinic Research Reveals Unique Tumor-Related Bacteria Tied to Young-Onset Colorectal CancerFebruary 5th, 2024
  • ‘I’m Terminal’ at 60: Why Are Colorectal Cancer Patients Getting Younger?
    ‘I’m Terminal’ at 60: Why Are Colorectal Cancer Patients Getting Younger?March 1st, 2023
  • Blood Test Could Help Predict Which Patients with Colon Cancer Need Chemotherapy After Surgery: Study
    Blood Test Could Help Predict Which Patients with Colon Cancer Need Chemotherapy After Surgery: StudyJanuary 17th, 2023
  • Join now to see all

Grant Support

  • Risk Factors For Venous Thromboembolism In Cancer Patients Receiving ChemotherapyNational Cancer Institute2006–2010